Seven Bridge Financial Group, LLC Vertex Pharmaceuticals Inc Transaction History
Seven Bridge Financial Group, LLC
- $478 Million
- Q1 2025
A detailed history of Seven Bridge Financial Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 514 shares of VRTX stock, worth $224,104. This represents 0.05% of its overall portfolio holdings.
Number of Shares
514
Previous 999
48.55%
Holding current value
$224,104
Previous $402,000
38.06%
% of portfolio
0.05%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding VRTX
# of Institutions
1,830Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.34 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.14 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...